AI-powered search

Can you expand on the off-label use of IL-17, IL-12, and IL-23 inhibitors for HS?

Featuring Saakshi Khattri , MD |

Assistant Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

| Published February 10, 2022

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved